| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1e472e52510b9a0150fb8bb983e5c5a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate |
2019-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1741fd828600c06b6ba5fba76fc8e16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a99e4189fc0435c2cbb05310b58d46e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0527d852dd63c09dbba25955589a1c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_048114909da9020e3983052fd1867922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a14721289f060bee404be9c11d5197e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3505ab97a92d04adac0de5d9d3bb44c2 |
| publicationDate |
2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3806868-A2 |
| titleOfInvention |
Exon skipping oligomers for muscular dystrophy |
| abstract |
Antisense oligomers complementary to a selected target site in the human dystrophin gene to induce exon 51 skipping are described. |
| priorityDate |
2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |